vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.
SouthState Bank Corp is the larger business by last-quarter revenue ($661.7M vs $451.8M, roughly 1.5× HALOZYME THERAPEUTICS, INC.). SouthState Bank Corp runs the higher net margin — 34.1% vs -31.3%, a 65.5% gap on every dollar of revenue. Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 37.4%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.
HALO vs SSB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $661.7M |
| Net Profit | $-141.6M | $225.8M |
| Gross Margin | 82.6% | — |
| Operating Margin | -20.6% | 15.1% |
| Net Margin | -31.3% | 34.1% |
| Revenue YoY | 51.6% | — |
| Net Profit YoY | -203.3% | 153.5% |
| EPS (diluted) | $-1.13 | $2.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $661.7M | ||
| Q4 25 | $451.8M | $581.1M | ||
| Q3 25 | $354.3M | $599.7M | ||
| Q2 25 | $325.7M | $577.9M | ||
| Q1 25 | $264.9M | $544.5M | ||
| Q4 24 | $298.0M | $369.8M | ||
| Q3 24 | $290.1M | $351.5M | ||
| Q2 24 | $231.4M | $350.3M |
| Q1 26 | — | $225.8M | ||
| Q4 25 | $-141.6M | $247.7M | ||
| Q3 25 | $175.2M | $246.6M | ||
| Q2 25 | $165.2M | $215.2M | ||
| Q1 25 | $118.1M | $89.1M | ||
| Q4 24 | $137.0M | $144.2M | ||
| Q3 24 | $137.0M | $143.2M | ||
| Q2 24 | $93.2M | $132.4M |
| Q1 26 | — | — | ||
| Q4 25 | 82.6% | — | ||
| Q3 25 | 84.4% | — | ||
| Q2 25 | 85.8% | — | ||
| Q1 25 | 81.7% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 82.9% | — |
| Q1 26 | — | 15.1% | ||
| Q4 25 | -20.6% | 54.3% | ||
| Q3 25 | 61.5% | 53.6% | ||
| Q2 25 | 62.2% | 48.8% | ||
| Q1 25 | 53.4% | 22.3% | ||
| Q4 24 | 58.9% | 50.7% | ||
| Q3 24 | 56.3% | 53.1% | ||
| Q2 24 | 50.7% | 49.3% |
| Q1 26 | — | 34.1% | ||
| Q4 25 | -31.3% | 42.6% | ||
| Q3 25 | 49.5% | 41.1% | ||
| Q2 25 | 50.7% | 37.2% | ||
| Q1 25 | 44.6% | 16.4% | ||
| Q4 24 | 46.0% | 39.0% | ||
| Q3 24 | 47.2% | 40.7% | ||
| Q2 24 | 40.3% | 37.8% |
| Q1 26 | — | $2.28 | ||
| Q4 25 | $-1.13 | $2.47 | ||
| Q3 25 | $1.43 | $2.42 | ||
| Q2 25 | $1.33 | $2.11 | ||
| Q1 25 | $0.93 | $0.87 | ||
| Q4 24 | $1.06 | $1.88 | ||
| Q3 24 | $1.05 | $1.86 | ||
| Q2 24 | $0.72 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $2.9B |
| Total DebtLower is stronger | $2.1B | — |
| Stockholders' EquityBook value | $48.8M | $9.0B |
| Total Assets | $2.5B | $68.0B |
| Debt / EquityLower = less leverage | 43.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $133.8M | — | ||
| Q3 25 | $419.7M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $176.3M | — | ||
| Q4 24 | $115.8M | — | ||
| Q3 24 | $154.3M | — | ||
| Q2 24 | $187.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — |
| Q1 26 | — | $9.0B | ||
| Q4 25 | $48.8M | $9.1B | ||
| Q3 25 | $503.9M | $9.0B | ||
| Q2 25 | $332.7M | $8.8B | ||
| Q1 25 | $482.3M | $8.6B | ||
| Q4 24 | $363.8M | $5.9B | ||
| Q3 24 | $452.7M | $5.9B | ||
| Q2 24 | $289.4M | $5.7B |
| Q1 26 | — | $68.0B | ||
| Q4 25 | $2.5B | $67.2B | ||
| Q3 25 | $2.2B | $66.0B | ||
| Q2 25 | $2.1B | $65.9B | ||
| Q1 25 | $2.2B | $65.1B | ||
| Q4 24 | $2.1B | $46.4B | ||
| Q3 24 | $2.1B | $46.1B | ||
| Q2 24 | $2.0B | $45.5B |
| Q1 26 | — | — | ||
| Q4 25 | 43.89× | — | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | — | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | — |
| Free Cash FlowOCF − Capex | $217.6M | — |
| FCF MarginFCF / Revenue | 48.2% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $219.0M | $232.1M | ||
| Q3 25 | $178.6M | $122.4M | ||
| Q2 25 | $99.7M | $72.6M | ||
| Q1 25 | $154.2M | $-126.3M | ||
| Q4 24 | $178.5M | $354.3M | ||
| Q3 24 | $115.4M | $-246.8M | ||
| Q2 24 | $55.8M | $126.8M |
| Q1 26 | — | — | ||
| Q4 25 | $217.6M | $215.5M | ||
| Q3 25 | $175.6M | $101.7M | ||
| Q2 25 | $98.1M | $52.5M | ||
| Q1 25 | $153.3M | $-139.1M | ||
| Q4 24 | $175.4M | $340.9M | ||
| Q3 24 | $113.9M | $-254.2M | ||
| Q2 24 | $53.2M | $117.3M |
| Q1 26 | — | — | ||
| Q4 25 | 48.2% | 37.1% | ||
| Q3 25 | 49.6% | 17.0% | ||
| Q2 25 | 30.1% | 9.1% | ||
| Q1 25 | 57.9% | -25.5% | ||
| Q4 24 | 58.9% | 92.2% | ||
| Q3 24 | 39.3% | -72.3% | ||
| Q2 24 | 23.0% | 33.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.9% | 3.5% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.4% | 2.4% | ||
| Q4 24 | 1.0% | 3.6% | ||
| Q3 24 | 0.5% | 2.1% | ||
| Q2 24 | 1.1% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | 1.02× | 0.50× | ||
| Q2 25 | 0.60× | 0.34× | ||
| Q1 25 | 1.31× | -1.42× | ||
| Q4 24 | 1.30× | 2.46× | ||
| Q3 24 | 0.84× | -1.72× | ||
| Q2 24 | 0.60× | 0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
